Consensus on timing of intervention for common congenital heart diseases: part II - cyanotic heart defects

P Syamasundar Rao1

  • 1Department of Pediatrics, Division of Pediatric Cardiology, The University of Texas-Houston Medical School/Children's Memorial Hermann Hospital, 6410 Fannin Street, UTPB Suite # 425, Houston, TX 77030, USA. p.syamasundar.rao@uth.tmc.edu

Insights

This review discusses the treatment of common cyanotic congenital heart defects (CHDs). Most cyanotic CHDs require intervention, primarily surgical, with timing based on lesion severity.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Disease
  • Cardiovascular Surgery

Background:

  • Cyanotic congenital heart defects (CHDs) represent a significant challenge in pediatric cardiology.
  • Unlike acyanotic CHDs, most cyanotic CHDs necessitate timely intervention to prevent long-term complications.

Purpose of the Study:

  • To provide a comprehensive overview of the treatment strategies for common cyanotic congenital heart defects (CHDs).
  • To delineate the indications and optimal timing for medical, transcatheter, and surgical interventions in cyanotic CHDs.

Main Methods:

  • This review synthesizes current medical literature and clinical guidelines.
  • It focuses on established surgical and transcatheter approaches for specific cyanotic CHDs.

Main Results:

  • Treatment for tetralogy of Fallot typically involves total surgical correction, with palliation as an option.
  • Transposition of the great arteries is managed with arterial switch (Jatene) or Rastelli procedures.
  • Tricuspid atresia and truncus arteriosus require staged palliation and surgical correction, respectively.
  • Total anomalous pulmonary venous connection necessitates prompt surgical anastomosis.

Conclusions:

  • Current medical, transcatheter, and surgical methods for treating cyanotic CHDs are effective and safe.
  • Intervention at the appropriate age is crucial to prevent irreversible damage to cardiovascular structures.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...